BRCA1 and BRCA2 genetic test for women under 50 with triple-negative breast cancer

BRCA1 and BRCA2 mutations

tests per year, UK, once

“Offer genetic testing for BRCA1 and BRCA2 mutations to women under 50 years with triple-negative breast cancer, including those with no family history of breast or ovarian cancer”

NICE NG101 Early and locally advanced breast cancer, recommendations, 2026-11-06

Kind of source
Clinical guideline
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
A one-off germline test for a defined group, not every patient with breast cancer.

Used in

Kept as evidence; no figure on the platform is computed from it yet.